Angion Provides Corporate Update and Reports Second Quarter 2021 Financial Results
August 12, 2021 16:05 ET | Angion Biomedica Corp.
-- Topline data in ANG-3777 Phase 3 study now expected to be announced in early Q4 rather than at year end -- Phase 1 data demonstrated ANG-3070 was well-tolerated across dose cohorts, achieving drug...
Angion and Vifor Pharma Announce Completion of Enrollment in Phase 2 Study of ANG-3777 for Cardiac-Surgery Associated Acute Kidney Injury
April 29, 2021 00:05 ET | Angion Biomedica Corp.
UNIONDALE, N.Y. and ST. GALLEN, Switzerland, April 29, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp (NASDAQ:ANGN) and Vifor Pharma today announced completion of enrollment for Angion’s AKI-002-15...
Logo - RBT.jpg
Renibus Therapeutics Initiates Phase 2 Study of RBT-1 for Prevention of Acute Kidney Injury
March 11, 2021 09:00 ET | Rénibus Therapeutics Inc.
- Renibus plans to enroll 126 subjects at up to 20 sites across the United States, Canada, Australia, and New Zealand DALLAS, Texas, March 11, 2021 (GLOBE NEWSWIRE) -- Renibus Therapeutics®...
ERAS 2021: CHF Solutions to Host On-Demand Presentation on Management of Fluid Overload in Cardiac Surgery Patients
March 04, 2021 08:00 ET | CHF Solutions, Inc.
EDEN PRAIRIE, Minn., March 04, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, will...
Logo - RBT.jpg
Renibus Therapeutics Announces Abstract Presentation at the 2020 European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Annual Congress
June 09, 2020 09:00 ET | Rénibus Therapeutics Inc.
Dallas, June 09, 2020 (GLOBE NEWSWIRE) -- Renibus Therapeutics, Inc, a clinical-stage biotechnology company, is pleased to announce that data highlighting the translation of the mechanism of action...
Reports and Data.jpeg-01
Cardiac surgery instruments Market To Reach USD 2.06 Billion By 2027 | Reports And Data
January 28, 2020 10:00 ET | Reports and Data
New York, Jan. 28, 2020 (GLOBE NEWSWIRE) -- The Global Cardiac Surgery Instruments Market is forecast to reach USD 2.06 Billion by 2027, according to a new report by Reports and Data. Cardiac...
Colibri HV Logo
Colibri Heart Valve Receives a United States Patent Directed to a Replacement Heart Valve that Includes a Dry Valve Sutured to a Stent Member
September 24, 2019 16:01 ET | Colibri Heart Valve, LLC
BROOMFIELD, CO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that U.S. Patent No. 10,390,945 (“the ‘945 Patent”) was...
RND logo.PNG
Global Surgical Glue Market To Reach USD 7.89 Billion By 2026 | Reports And Data
May 08, 2019 11:08 ET | Reports And Data
The technological advancements in the healthcare industry, as well as the increase in the aged population, are influencing the market growth. Market Size – USD 4.09 Billion in 2018, Market Growth -...
The American Health Council Welcomes Hartmuth B. Bittner, MD, Ph.D., FACS to its Board of Physicians
September 19, 2018 08:00 ET | American Health Council
NEW YORK, Sept. 19, 2018 (GLOBE NEWSWIRE) -- The American Health Council welcomes Hartmuth B. Bittner, MD, Ph.D., FACS to its Board of Physicians for his outstanding contributions to the medical...
Colibri HV Logo
Colibri Heart Valve to Present Six Month Follow-up Results from First Clinical Use at Upcoming EuroPCR Meeting
May 16, 2013 08:00 ET | Colibri Heart Valve LLC
BROOMFIELD, CO, May 16, 2013 (GLOBE NEWSWIRE) -- Colibri Heart Valve, LLC, a privately held medical device company, today announced that Dr. Pedro Ureña will present six month follow-up results...